MUMBAI, India, Oct. 12 -- Intellectual Property India has published a patent application (202611056175 A) filed by Isf College Of Pharmacy on May 03, 2026, for Design, Synthesis And Biological Evaluation Of Quinazolinone-Hydroxamate Hybrids As Dual Inhibitors For The Treatment Of Cancer And Bacterial Resistance.
Inventors include Sakshi Priya; Md Mustahidul Islam; Preeti Patel; Balak Das Kurmi; Shivani Kasana; Ghanshyam Das Gupta; and Kanchan Pal.
The application for the patent was published on October 09, 2026, under issue no. 41/2026.
Abstract: The present invention discloses a process for the synthesis and biological evaluation of Quinazolinone-Hydroxamate Hybrid derivatives [SP01-SP10] as dual inhibitor for the treatment of cancer and bacterial resistance. The structures of the discovered compounds were clarified using IR, IHNMR, 13C NMR and mass spectrometry.
Disclaimer: Curated by HT Syndication.
